Current
—
5-Year Average
—
All-Time High
—
All-Time Low
—
P/E Ratio daily chart for Erasca (ERAS)
Jul 16, 2021 – Jun 12, 2026 · 1,233 trading days
P/E ratio is not shown for periods when TTM earnings were negative.
Historical P/E Ratio for Erasca (ERAS) from 2020 to 2025
| 2025 | $1.05B | −$124.55M | — | — | |
| 2024 | $709.94M | −$161.65M | — | — | |
| 2023 | $321.06M | −$125.04M | — | — | |
| 2022 | $549.70M | −$242.81M | — | — | |
| 2021 | $1.85B | −$122.76M | — | — | |
| 2020 | $2.07B | −$101.66M | — | — |
- 2025—
- 2024—
- 2023—
- 2022—
- 2021—
- 2020—
About P/E Ratio at Erasca (ERAS)
The price-to-earnings (P/E) ratio, also called the earnings multiple, measures how much investors pay per dollar of a company's trailing twelve-month (TTM) earnings. It is calculated as share price ÷ TTM diluted EPS (equivalent to market capitalisation ÷ TTM net income). A higher P/E implies the market is pricing in stronger future earnings growth or lower risk; a lower P/E can signal slower expected growth, higher risk, or potential undervaluation.
Sector peers by P/E Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/E Ratio — table
Healthcare peers of Erasca (ERAS), ranked by P/E ratio.
| 22.2× | |
| 22.2× | |
| 21.7× | |
| 21.6× | |
| 21.6× | |
| 21.1× | |
| 21.1× | |
| 21.0× | |
| 20.9× | |
| 20.7× | |
| 20.4× | |
| 19.7× | |
| 18.9× | |
| 18.8× | |
| 18.5× | |
| 18.2× | |
| 17.0× | |
| 15.8× | |
| 13.3× | |
| 13.1× | |
| 12.3× | |
| 11.1× | |
| 8.6× | |
| 7.9× | |
| 7.2× |
- 22.2×
- 22.2×
- 21.7×
- 21.6×
- 21.6×
- 21.1×
- 21.0×
- 20.9×
- 20.7×
- 19.7×
- 18.9×
- 18.5×
- 15.8×
- 13.3×
- 13.1×
- 11.1×
- 7.9×
Frequently asked questions
Erasca (ERAS) Key Financials
Charts, filings, and peer comparison for every metric